Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 284 entries
Sorted by: Best Match Show Resources per page
Soluble P-selectin assay: importance of correct anticoagulant choice.

Platelets

Kirk G, McLaren M, Belch JF.
PMID: 20297938
Platelets. 1997;8(2):159-62. doi: 10.1080/09537109709169332.

P-selectin is stored preformed in the alpha-granules of platelets. Previous studies show ss-thromboglobulin, also stored in alpha-granules can be readily released from platelets during the processing of whole blood. This artefactual release was rectified by using combination of various...

Cite
Kirk G, McLaren M, Belch JF. Soluble P-selectin assay: importance of correct anticoagulant choice. Platelets. 1997;8(2):159-62doi: 10.1080/09537109709169332.
Kirk, G., McLaren, M., & Belch, J. F. (1997). Soluble P-selectin assay: importance of correct anticoagulant choice. Platelets, 8(2), 159-62. https://doi.org/10.1080/09537109709169332
Kirk, G, et al. "Soluble P-selectin assay: importance of correct anticoagulant choice." Platelets vol. 8,2 (1997): 159-62. doi: https://doi.org/10.1080/09537109709169332
Kirk G, McLaren M, Belch JF. Soluble P-selectin assay: importance of correct anticoagulant choice. Platelets. 1997;8(2):159-62. doi: 10.1080/09537109709169332. PMID: 20297938.
Copy Download .nbib Format: NLM
Kinetic and inhibitor specificity of adenosine transport in guinea pig cerebral cortical synaptosomes: evidence for two nucleoside transporters.

Neurochemistry international

Lee CW, Jarvis SM.
PMID: 20501255
Neurochem Int. 1988;12(4):483-92. doi: 10.1016/0197-0186(88)90032-0.

The transport of [(3)H]adenosine at 22 degrees C was investigated in guinea pig cerebral cortical synaptosomes using an inhibitor-stop filtration method. Under these conditions adenosine was not significantly metabolized during the incubation period used to determine the initial rates...

Cite
Lee CW, Jarvis SM. Kinetic and inhibitor specificity of adenosine transport in guinea pig cerebral cortical synaptosomes: evidence for two nucleoside transporters. Neurochem Int. 1988;12(4):483-92doi: 10.1016/0197-0186(88)90032-0.
Lee, C. W., & Jarvis, S. M. (1988). Kinetic and inhibitor specificity of adenosine transport in guinea pig cerebral cortical synaptosomes: evidence for two nucleoside transporters. Neurochemistry international, 12(4), 483-92. https://doi.org/10.1016/0197-0186(88)90032-0
Lee, C W, and Jarvis, S M. "Kinetic and inhibitor specificity of adenosine transport in guinea pig cerebral cortical synaptosomes: evidence for two nucleoside transporters." Neurochemistry international vol. 12,4 (1988): 483-92. doi: https://doi.org/10.1016/0197-0186(88)90032-0
Lee CW, Jarvis SM. Kinetic and inhibitor specificity of adenosine transport in guinea pig cerebral cortical synaptosomes: evidence for two nucleoside transporters. Neurochem Int. 1988;12(4):483-92. doi: 10.1016/0197-0186(88)90032-0. PMID: 20501255.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayes M, Rabasseda X, Prous JR.
PMID: 18040531
Methods Find Exp Clin Pharmacol. 2007 Oct;29(8):547-83.

(-)-Epigallocatechin gallate, [188Re]-P2045, 12B75, 89-12; Abacavir sulfate/lamivudine, Abatacept, Abiraterone acetate, ABT-869, Adalimumab, Ad-rh Endostatin, AI-700, Alemtuzumab, Alvimopan hydrate, Amrubicin hydrochloride, AP-12009, Apomab 7.3, Arformoterol tartrate, Aripiprazole, AS-1404, Azacitidine, AZD-0530; Bevacizumab, BHT-3009, Biapenem, Bortezomib, Bosentan, Bremelanotide; CA9-SCAN, Calcitonin gene-related peptide,...

Cite
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2007;29(8):547-83
Bayes, M., Rabasseda, X., & Prous, J. R. (2007). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 29(8), 547-83.
Bayes, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 29,8 (2007): 547-83.
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2007 Oct;29(8):547-83. PMID: 18040531.
Copy Download .nbib Format: NLM
Stress echocardiography.

Current pharmaceutical design

Picano E, Pasanisi E, Venneri L, Agrusta M, Mottola G, Sicari R.
PMID: 16026284
Curr Pharm Des. 2005;11(17):2137-49. doi: 10.2174/1381612054367454.

Stress echocardiography is the combination of 2D echocardiography with a physical, pharmacological or electrical stress. The diagnostic end point for the detection of myocardial ischemia is the induction of a transient worsening in regional function during stress. Stress echocardiography...

Cite
Picano E, Pasanisi E, Venneri L, et al. Stress echocardiography. Curr Pharm Des. 2005;11(17):2137-49doi: 10.2174/1381612054367454.
Picano, E., Pasanisi, E., Venneri, L., Agrusta, M., Mottola, G., & Sicari, R. (2005). Stress echocardiography. Current pharmaceutical design, 11(17), 2137-49. https://doi.org/10.2174/1381612054367454
Picano, E, et al. "Stress echocardiography." Current pharmaceutical design vol. 11,17 (2005): 2137-49. doi: https://doi.org/10.2174/1381612054367454
Picano E, Pasanisi E, Venneri L, Agrusta M, Mottola G, Sicari R. Stress echocardiography. Curr Pharm Des. 2005;11(17):2137-49. doi: 10.2174/1381612054367454. PMID: 16026284.
Copy Download .nbib Format: NLM
Biphasic increase of gap junction coupling induced by dipyridamole in the rat aortic A-10 vascular smooth muscle cell line.

Journal of cell communication and signaling

Begandt D, Bader A, Dreyer L, Eisert N, Reeck T, Ngezahayo A.
PMID: 23483357
J Cell Commun Signal. 2013 Jun;7(2):151-60. doi: 10.1007/s12079-013-0196-4. Epub 2013 Mar 13.

The rat aortic smooth muscle cell line A-10 was used to investigate the effect of dipyridamole on the gap junction coupling of smooth muscle cells. The scrape loading/dye transfer (SL/DT) technique revealed that dipyridamole concentrations between 5 μM and...

Cite
Begandt D, Bader A, Dreyer L, et al. Biphasic increase of gap junction coupling induced by dipyridamole in the rat aortic A-10 vascular smooth muscle cell line. J Cell Commun Signal. 2013;7(2):151-60doi: 10.1007/s12079-013-0196-4.
Begandt, D., Bader, A., Dreyer, L., Eisert, N., Reeck, T., & Ngezahayo, A. (2013). Biphasic increase of gap junction coupling induced by dipyridamole in the rat aortic A-10 vascular smooth muscle cell line. Journal of cell communication and signaling, 7(2), 151-60. https://doi.org/10.1007/s12079-013-0196-4
Begandt, Daniela, et al. "Biphasic increase of gap junction coupling induced by dipyridamole in the rat aortic A-10 vascular smooth muscle cell line." Journal of cell communication and signaling vol. 7,2 (2013): 151-60. doi: https://doi.org/10.1007/s12079-013-0196-4
Begandt D, Bader A, Dreyer L, Eisert N, Reeck T, Ngezahayo A. Biphasic increase of gap junction coupling induced by dipyridamole in the rat aortic A-10 vascular smooth muscle cell line. J Cell Commun Signal. 2013 Jun;7(2):151-60. doi: 10.1007/s12079-013-0196-4. Epub 2013 Mar 13. PMID: 23483357; PMCID: PMC3660691.
Copy Download .nbib Format: NLM
Nuclear scan strategy and outcomes in chest pain patients value of stress testing with dipyridamole or adenosine.

World journal of nuclear medicine

Conti A, Mariannini Y, Canuti E, Petrova T, Innocenti F, Zanobetti M, Gallini C, Costanzo E.
PMID: 25191123
World J Nucl Med. 2014 May;13(2):94-101. doi: 10.4103/1450-1147.139138.

OBJECTIVE: To update the prognostic value of scan strategy with pharmacological stress agent in chest pain (CP) patients presenting with normal electrocardiography (ECG) and troponin.METHODS: Two consecutive nonrandomized series of patients with CP and negative first-line workup inclusive of...

Cite
Conti A, Mariannini Y, Canuti E, et al. Nuclear scan strategy and outcomes in chest pain patients value of stress testing with dipyridamole or adenosine. World J Nucl Med. 2014;13(2):94-101doi: 10.4103/1450-1147.139138.
Conti, A., Mariannini, Y., Canuti, E., Petrova, T., Innocenti, F., Zanobetti, M., Gallini, C., & Costanzo, E. (2014). Nuclear scan strategy and outcomes in chest pain patients value of stress testing with dipyridamole or adenosine. World journal of nuclear medicine, 13(2), 94-101. https://doi.org/10.4103/1450-1147.139138
Conti, Alberto, et al. "Nuclear scan strategy and outcomes in chest pain patients value of stress testing with dipyridamole or adenosine." World journal of nuclear medicine vol. 13,2 (2014): 94-101. doi: https://doi.org/10.4103/1450-1147.139138
Conti A, Mariannini Y, Canuti E, Petrova T, Innocenti F, Zanobetti M, Gallini C, Costanzo E. Nuclear scan strategy and outcomes in chest pain patients value of stress testing with dipyridamole or adenosine. World J Nucl Med. 2014 May;13(2):94-101. doi: 10.4103/1450-1147.139138. PMID: 25191123; PMCID: PMC4150166.
Copy Download .nbib Format: NLM
Comparing a High-dose Dipyridamole SPECT Imaging Protocol with Dobutamine and Exercise Stress Testing Protocols. Part III: Using Dobutamine to Determine Lung-to-Heart Ratios, Left Ventricular Dysfunction, and a Potential Viability Marker.

The International journal of angiology : official publication of the International College of Angiology, Inc

Feldmann KM, Fleming RM, Fleming DM.
PMID: 9826402
Int J Angiol. 1999 Jan;8(1):22-26. doi: 10.1007/BF01616837.

Determination of the severity of coronary artery disease (CAD) by single photon emission computed tomography (SPECT) imaging has previously been shown to have greater sensitivity, specificity, and accuracy when performed with pharmacologic stress using dobutamine than by standard dose...

Cite
Feldmann KM, Fleming RM, Fleming DM. Comparing a High-dose Dipyridamole SPECT Imaging Protocol with Dobutamine and Exercise Stress Testing Protocols. Part III: Using Dobutamine to Determine Lung-to-Heart Ratios, Left Ventricular Dysfunction, and a Potential Viability Marker. Int J Angiol. 1999;8(1):22-26doi: 10.1007/BF01616837.
Feldmann, K. M., Fleming, R. M., & Fleming, D. M. (1999). Comparing a High-dose Dipyridamole SPECT Imaging Protocol with Dobutamine and Exercise Stress Testing Protocols. Part III: Using Dobutamine to Determine Lung-to-Heart Ratios, Left Ventricular Dysfunction, and a Potential Viability Marker. The International journal of angiology : official publication of the International College of Angiology, Inc, 8(1), 22-26. https://doi.org/10.1007/BF01616837
Feldmann, et al. "Comparing a High-dose Dipyridamole SPECT Imaging Protocol with Dobutamine and Exercise Stress Testing Protocols. Part III: Using Dobutamine to Determine Lung-to-Heart Ratios, Left Ventricular Dysfunction, and a Potential Viability Marker." The International journal of angiology : official publication of the International College of Angiology, Inc vol. 8,1 (1999): 22-26. doi: https://doi.org/10.1007/BF01616837
Feldmann KM, Fleming RM, Fleming DM. Comparing a High-dose Dipyridamole SPECT Imaging Protocol with Dobutamine and Exercise Stress Testing Protocols. Part III: Using Dobutamine to Determine Lung-to-Heart Ratios, Left Ventricular Dysfunction, and a Potential Viability Marker. Int J Angiol. 1999 Jan;8(1):22-26. doi: 10.1007/BF01616837. PMID: 9826402.
Copy Download .nbib Format: NLM
Atrial Arrhythmias and Scintigraphic "D-shape" Sign in Pulmonary Artery Hypertension.

World journal of nuclear medicine

Ferrando-Castagnetto F, Ricca-Mallada R, Selios V, Ferrando R.
PMID: 28217026
World J Nucl Med. 2017 Jan-Mar;16(1):75-77. doi: 10.4103/1450-1147.181152.

Pulmonary hypertension significantly changes biventricular anatomy and physiology, frequently evolving to clinical deterioration and right ventricular failure. The case of a woman developing atrial arrhythmias complicating dipyridamole stress in concomitance with scintigraphic "D-shaped" left ventricle is briefly reported. Although...

Cite
Ferrando-Castagnetto F, Ricca-Mallada R, Selios V, et al. Atrial Arrhythmias and Scintigraphic "D-shape" Sign in Pulmonary Artery Hypertension. World J Nucl Med. 2017;16(1):75-77doi: 10.4103/1450-1147.181152.
Ferrando-Castagnetto, F., Ricca-Mallada, R., Selios, V., & Ferrando, R. (2017). Atrial Arrhythmias and Scintigraphic "D-shape" Sign in Pulmonary Artery Hypertension. World journal of nuclear medicine, 16(1), 75-77. https://doi.org/10.4103/1450-1147.181152
Ferrando-Castagnetto, Federico, et al. "Atrial Arrhythmias and Scintigraphic "D-shape" Sign in Pulmonary Artery Hypertension." World journal of nuclear medicine vol. 16,1 (2017): 75-77. doi: https://doi.org/10.4103/1450-1147.181152
Ferrando-Castagnetto F, Ricca-Mallada R, Selios V, Ferrando R. Atrial Arrhythmias and Scintigraphic "D-shape" Sign in Pulmonary Artery Hypertension. World J Nucl Med. 2017 Jan-Mar;16(1):75-77. doi: 10.4103/1450-1147.181152. PMID: 28217026; PMCID: PMC5314670.
Copy Download .nbib Format: NLM
Dipyridamole-induced adverse effects in myocardial perfusion scans: Dynamic evaluation.

International journal of cardiology. Heart & vasculature

Lee SD, Huang WC, Peng NJ, Hu C.
PMID: 28616557
Int J Cardiol Heart Vasc. 2016 Nov 27;14:14-19. doi: 10.1016/j.ijcha.2016.11.002. eCollection 2017 Mar.

AIM AND BACKGROUND: Dipyridamole-induced stress myocardial perfusion scans (MPS) has been widely used for management of coronary artery disease. The adverse effects of dipyridamole and other stress agents have been evaluated. The aim of this research is to confirm...

Cite
Lee SD, Huang WC, Peng NJ, et al. Dipyridamole-induced adverse effects in myocardial perfusion scans: Dynamic evaluation. Int J Cardiol Heart Vasc. 2016;14:14-19doi: 10.1016/j.ijcha.2016.11.002.
Lee, S. D., Huang, W. C., Peng, N. J., & Hu, C. (2017). Dipyridamole-induced adverse effects in myocardial perfusion scans: Dynamic evaluation. International journal of cardiology. Heart & vasculature, 1414-19. https://doi.org/10.1016/j.ijcha.2016.11.002
Lee, Sin-Di, et al. "Dipyridamole-induced adverse effects in myocardial perfusion scans: Dynamic evaluation." International journal of cardiology. Heart & vasculature vol. 14 (2017): 14-19. doi: https://doi.org/10.1016/j.ijcha.2016.11.002
Lee SD, Huang WC, Peng NJ, Hu C. Dipyridamole-induced adverse effects in myocardial perfusion scans: Dynamic evaluation. Int J Cardiol Heart Vasc. 2016 Nov 27;14:14-19. doi: 10.1016/j.ijcha.2016.11.002. eCollection 2017 Mar. PMID: 28616557; PMCID: PMC5454177.
Copy Download .nbib Format: NLM
Massive pericardial effusion: A rare and easily missed finding in myocardial perfusion scintigraphy.

World journal of nuclear medicine

Wu KK, Kung BT, Au Yong TK.
PMID: 30034286
World J Nucl Med. 2018 Jul-Sep;17(3):198-200. doi: 10.4103/wjnm.WJNM_39_17.

A 72-year-old gentleman underwent myocardial perfusion scintigraphy (MPS) for sinus tachycardia of unknown cause. Baseline electrocardiography (ECG) showed sinus tachycardia and electrical alternans. Thallium-201 stress-redistribution MPS was performed with dipyridamole stress. On the raw projection images, a photopenic "halo"...

Cite
Wu KK, Kung BT, Au Yong TK. Massive pericardial effusion: A rare and easily missed finding in myocardial perfusion scintigraphy. World J Nucl Med. 2018;17(3):198-200doi: 10.4103/wjnm.WJNM_39_17.
Wu, K. K., Kung, B. T., & Au Yong, T. K. (2018). Massive pericardial effusion: A rare and easily missed finding in myocardial perfusion scintigraphy. World journal of nuclear medicine, 17(3), 198-200. https://doi.org/10.4103/wjnm.WJNM_39_17
Wu, Kwan Kit, et al. "Massive pericardial effusion: A rare and easily missed finding in myocardial perfusion scintigraphy." World journal of nuclear medicine vol. 17,3 (2018): 198-200. doi: https://doi.org/10.4103/wjnm.WJNM_39_17
Wu KK, Kung BT, Au Yong TK. Massive pericardial effusion: A rare and easily missed finding in myocardial perfusion scintigraphy. World J Nucl Med. 2018 Jul-Sep;17(3):198-200. doi: 10.4103/wjnm.WJNM_39_17. PMID: 30034286; PMCID: PMC6034550.
Copy Download .nbib Format: NLM
Early Risk Stratification with Dipyridamole Stress Echo in a Patient with Intermediate Lesion in the Right Coronary Artery, 24 Hours after Percutaneous Coronary Intervention.

The West Indian medical journal

Carmargo S, Rampersad RD.
PMID: 26360689
West Indian Med J. 2015 Mar;64(2):145-6. doi: 10.7727/wimj.2013.141. Epub 2015 Feb 10.

No abstract available.

Cite
Carmargo S, Rampersad RD. Early Risk Stratification with Dipyridamole Stress Echo in a Patient with Intermediate Lesion in the Right Coronary Artery, 24 Hours after Percutaneous Coronary Intervention. West Indian Med J. 2015;64(2):145-6doi: 10.7727/wimj.2013.141.
Carmargo, S., & Rampersad, R. D. (2015). Early Risk Stratification with Dipyridamole Stress Echo in a Patient with Intermediate Lesion in the Right Coronary Artery, 24 Hours after Percutaneous Coronary Intervention. The West Indian medical journal, 64(2), 145-6. https://doi.org/10.7727/wimj.2013.141
Carmargo, S, and Rampersad, R D. "Early Risk Stratification with Dipyridamole Stress Echo in a Patient with Intermediate Lesion in the Right Coronary Artery, 24 Hours after Percutaneous Coronary Intervention." The West Indian medical journal vol. 64,2 (2015): 145-6. doi: https://doi.org/10.7727/wimj.2013.141
Carmargo S, Rampersad RD. Early Risk Stratification with Dipyridamole Stress Echo in a Patient with Intermediate Lesion in the Right Coronary Artery, 24 Hours after Percutaneous Coronary Intervention. West Indian Med J. 2015 Mar;64(2):145-6. doi: 10.7727/wimj.2013.141. Epub 2015 Feb 10. PMID: 26360689; PMCID: PMC4696622.
Copy Download .nbib Format: NLM
Phase i/ii trial of 5-Fluorouracil, leucovorin, Zidovudine and dipyridamole for patients with metastatic colorectal-cancer, renal-cell carcinoma and malignant-melanoma.

International journal of oncology

Sharfman W, Urba W, Smith J, Janik J, Curti B, Gause B, Holmlund J, Steis R, Beauchamp A, Longo D.
PMID: 21556574
Int J Oncol. 1995 Mar;6(3):579-83. doi: 10.3892/ijo.6.3.579.

We conducted a phase I/II trial of 5-fluorouracil (5-FU), calcium leucovorin (LV), zidovudine (AZT) and dipyridamole (DP), (FLAP) in patients with metastatic colorectal cancer, renal cell carcinoma and malignant melanoma. AZT and DP were given to enhance the biochemical...

Cite
Sharfman W, Urba W, Smith J, et al. Phase i/ii trial of 5-Fluorouracil, leucovorin, Zidovudine and dipyridamole for patients with metastatic colorectal-cancer, renal-cell carcinoma and malignant-melanoma. Int J Oncol. 1995;6(3):579-83doi: 10.3892/ijo.6.3.579.
Sharfman, W., Urba, W., Smith, J., Janik, J., Curti, B., Gause, B., Holmlund, J., Steis, R., Beauchamp, A., & Longo, D. (1995). Phase i/ii trial of 5-Fluorouracil, leucovorin, Zidovudine and dipyridamole for patients with metastatic colorectal-cancer, renal-cell carcinoma and malignant-melanoma. International journal of oncology, 6(3), 579-83. https://doi.org/10.3892/ijo.6.3.579
Sharfman, W, et al. "Phase i/ii trial of 5-Fluorouracil, leucovorin, Zidovudine and dipyridamole for patients with metastatic colorectal-cancer, renal-cell carcinoma and malignant-melanoma." International journal of oncology vol. 6,3 (1995): 579-83. doi: https://doi.org/10.3892/ijo.6.3.579
Sharfman W, Urba W, Smith J, Janik J, Curti B, Gause B, Holmlund J, Steis R, Beauchamp A, Longo D. Phase i/ii trial of 5-Fluorouracil, leucovorin, Zidovudine and dipyridamole for patients with metastatic colorectal-cancer, renal-cell carcinoma and malignant-melanoma. Int J Oncol. 1995 Mar;6(3):579-83. doi: 10.3892/ijo.6.3.579. PMID: 21556574.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 284 entries